Nuotai Biopharm funding history / development milestones

IPO上市，

2021.05.20，上交所

Note: collected from public online reports, for reference only.

Talent Demand Trend Analysis More

制药/药业

原料药

基因工程

多肽原料药

多肽

医药

生物医药

生物制药

医药中间体

生物原料

中间体

药物研发

原料

免疫调节

医药原料药

People who follow Nuotai Biopharm also follow

Nuotai Biopharm Competitors (Similar Companies)

Follow in Bulk Copy Company Names

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

“Research, development, and production of anti-tumor and surgical medic”

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

“A renowned enterprise in China's liver disease and anti-tumor fields”

江苏联瑞新材料股份有限公司

“无机填料和颗粒载体”

Jiangsu Kanion Pharmaceutical Co., Ltd.

“A large traditional Chinese medicine enterprise integrating R&D, produ”

Jiangsu Enhua Pharmaceutical Co., Ltd.

“Leading enterprise in the field of central nervous system drugs in Chi”

Innovent Biologics (Suzhou) Co., Ltd.

“To develop high-quality biologics that are accessible and affordable f”

BeiGene (Beijing) Biologics Co., Ltd.

“Dedicated to the research and development of molecularly targeted drug”

杭州澳赛诺生物科技有限公司

生物科技/生物工程生物制剂药物研发生物医药

Wuxi WuXi Biologics Co., Ltd.

“Accelerating global biologic drug R&D processes, reducing R&D costs, a”

Wecon Probiotics (Suzhou) Co., Ltd.

“Developer of probiotics and derivatives”

宁波美诺华药业股份有限公司

“主营医药中间体、原料药和成品药的研发、生产与销售”

Jiangsu Coast Pharmaceutical Co., Ltd.

制药/药业软膏剂生物制品乳膏剂

美药星（南京）制药有限公司

“是一家集药品研发、化学及生化药品中间体合成、分析检测及原料药生产于一体的高科技医药研发生产企业”

暨明医药科技（苏州）有限公司

制药/药业生物制药医药中间体原料药

昭衍（苏州）新药研究中心有限公司

医药药效学研究生物制品生物医药

中 中文版 View this page in Chinese ›